For doctors

For Referring Doctors: Ocular Oncology Referral Criteria

Prof. Dr. Elif Betül Türkoğlu, an ocular oncologist in Antalya, accepts referrals of adults and children with suspected intraocular, conjunctival, eyelid and orbital tumors. Urgent referral is appropriate for suspected retinoblastoma and for a pigmented choroidal lesion with a MOLES score of 3 or more, or with documented growth. The same applies to suspected conjunctival melanoma or ocular surface squamous neoplasia and to a fast-growing eyelid or orbital lesion. The referring doctor is informed of the findings and the proposed plan.
Urgent
leukocoria; MOLES ≥3 or growth; suspected conjunctival melanoma or OSSN; fast-growing lid or orbital mass
Routine
nevi with 1–2 risk factors; benign lesions that need documentation
Send
dated photographs, ultrasound, OCT, DICOM files, pathology
Contact
request form on this page, topic Referral from a doctor; check Urgent for urgent cases

I wrote this page for ophthalmologists, optometrists, pediatricians, oncologists and other clinicians who want to refer a patient for an ocular oncology assessment in Türkiye. I am a Professor of Ophthalmology and an ocular oncologist, with more than 20 years in ophthalmology. My academic career was at the Akdeniz University Faculty of Medicine, where I became a full professor in 2022. My training in ocular oncology includes a one-year research fellowship at Wills Eye Hospital, Philadelphia (2015–2016), and an observership at the National Cancer Center of Japan (2019). My profile gives the details.

At my practice in Antalya I see adults and children with intraocular, conjunctival, eyelid and orbital tumors. I also accept referrals for orbital decompression, anophthalmic socket revision, probing and DCR, and strabismus surgery, and I review imaging sent from other cities and countries. The criteria below follow published triage tools. They support your clinical judgment; they do not replace it.

Which patients should be referred urgently?

Please refer promptly with the request form at the end of this page, and check the Urgent box, when you see:

Finding Why it matters
Leukocoria, an abnormal or asymmetric red reflex, or a new strabismus in a young child Leukocoria is the most common presenting sign of retinoblastoma; strabismus is the second most common
A pigmented choroidal lesion with a MOLES score of 3 or more, or documented growth A score of 3 or more indicates probable melanoma; growth is the key sign of transformation
Suspected conjunctival melanoma: a new or enlarging pigmented lesion in an adult, nodularity, feeder vessels, or a site outside the bulbar conjunctiva Complete "no-touch" excision at the first operation is preferred to incisional biopsy
Suspected ocular surface squamous neoplasia (OSSN): a gelatinous or leukoplakic limbal lesion with corkscrew vessels, especially if it is nodular, fixed to the globe or has large feeder vessels These are signs of possible invasive carcinoma, which needs staging and treatment planning
A rapidly growing eyelid lesion with ulceration, bleeding, lash loss or lid-margin destruction, or a "chalazion" that recurs in the same place Features of eyelid malignancy, including sebaceous carcinoma
Rapidly progressive proptosis or an orbital mass, especially in a child Rhabdomyosarcoma must be excluded with urgent imaging and biopsy
Thyroid eye disease with suspected optic nerve compression that does not improve within 1–2 weeks of high-dose intravenous steroids Guidelines recommend urgent orbital decompression

MOLES and TFSOM-DIM in brief

MOLES was developed by Professor Bertil Damato for optometrists and general ophthalmologists. It scores five features, each from 0 to 2: Mushroom shape, Orange pigment, Large size, Enlargement and Subretinal fluid. A total of 0 suggests a common nevus. A score of 1–2 suggests a low- or high-risk nevus, which warrants non-urgent referral for imaging. A score of 3 or more suggests a probable melanoma and warrants urgent referral. In validation series from Moorfields (222 tumors) and from Germany (695 nevi and 53 melanomas), a score of 3 or more identified every melanoma, with a specificity of about 96%.

TFSOM-DIM comes from the Wills Eye Ocular Oncology Service (3,806 nevi). It lists six imaging features:

  • Thickness over 2 mm on ultrasound
  • Subretinal Fluid on OCT
  • Symptoms, with vision of 20/50 or worse
  • Orange pigment on autofluorescence
  • Melanoma acoustic hollowness on ultrasound
  • DIaMeter over 5 mm on photography

The five-year transformation rate rose from about 1% with no factors to 11% with one, 22% with two, 34% with three and about half with four or more. The choroidal nevus page explains both systems for patients.

Which patients can be referred routinely?

  • Choroidal nevi with one or two risk factors (MOLES 1–2), for baseline multimodal imaging and a follow-up plan. Published guidance suggests re-imaging such lesions every 4–6 months at first.
  • Benign-looking lesions that need documentation or a second opinion. Examples include a stable conjunctival or iris nevus, congenital hypertrophy of the retinal pigment epithelium (CHRPE) and a small, stable eyelid lesion.
  • Atypical pterygium or pinguecula (temporal only, leukoplakic, unusually vascular or quickly recurrent), to exclude OSSN.
  • Cataract in eyes treated for an intraocular tumor, and other complex lens surgery; see complex cataract surgery.
  • Oculoplastic, orbital and strabismus surgery: inactive thyroid eye disease with proptosis, for orbital decompression; anophthalmic socket problems such as implant exposure or a contracted socket (socket revision); congenital or acquired nasolacrimal duct obstruction, for probing or DCR; and strabismus in children and adults (strabismus surgery).

Before you refer

  • Please avoid incisional biopsy of a suspected nodular conjunctival melanoma, or of a well-circumscribed lacrimal gland mass that may be a pleomorphic adenoma. Both should be excised intact.
  • In a child with suspected retinoblastoma, prefer MRI to CT, and do not biopsy the eye.
  • Send every excised pterygium for histopathology: unsuspected OSSN has been reported in 1.7–9.8% of specimens.
  • If an intraocular tumor cannot be excluded, for example when the fundus is not visible, obtain an ultrasound before any evisceration.

What should you send with a referral?

  • Patient details, contact information and preferred language, and the question you would like me to answer.
  • History: onset and course of the symptoms, previous eye treatment, previous cancers, relevant family history (for example retinoblastoma, uveal melanoma or BAP1-related tumors), general health and medicines.
  • Visual acuity and intraocular pressure of both eyes.
  • Dated imaging: wide-field color fundus photographs; A- and B-scan ultrasound with thickness and largest basal diameter; OCT; fundus autofluorescence; angiography if performed. For surface lesions, slit-lamp photographs that include the everted lids and fornices, and anterior segment OCT. For orbital lesions, MRI or CT.
  • Earlier images for comparison. Documented change is often decisive.
  • Pathology reports, operative notes and details of previous treatment; where possible, slides or blocks for review.
  • For children: red reflex findings, family photographs showing leukocoria and any RB1 genetic results.

Please send scans as DICOM files or full-resolution images through a secure cloud link, not as screenshots. Paste the link into the field Link to scans or reports of the request form, or send it in reply to the practice's message. Share records with the patient's consent (see the privacy notice). The tests themselves are described on the page about eye tumor diagnosis.

How do I report back, and how does shared care work?

After the consultation I let you know the examination and imaging findings, the working diagnosis, the options I discussed with the patient, and the recommended plan and follow-up interval. Where it suits the patient, follow-up examinations and imaging can take place with you. You then send them to me for remote review, so the patient does not need to travel for every visit.

I evaluate each case and plan treatment with the patient. Some methods need specialized facilities: plaque brachytherapy, proton or stereotactic radiotherapy, intra-arterial chemotherapy and systemic therapy. These are given together with the relevant specialist teams, and I keep you informed of the plan.

How can you reach me?

Send urgent and routine referrals with the request form below and choose the topic Referral from a doctor. For an urgent case, check the Urgent box. The practice replies by the method you choose: WhatsApp, Telegram, phone call or e-mail. We can correspond in English or Turkish.

The practice is not an emergency service: send a patient who needs emergency care to the nearest emergency department (112 in Türkiye).

Request form

Describe your question in a few lines and choose how you would like to receive the reply. This form is not for emergencies: if you need urgent help, call your local emergency number (112 in Türkiye).

Fields marked * are required.

Choose the country by its flag, then type the number. Used for WhatsApp, Telegram or a call.

Needed only if you choose a reply by e-mail.

Which eye, what was found and when; the diagnosis and any treatment so far; your question.

A shared link to Google Drive, Dropbox, WeTransfer or a similar service. Put all files in one folder and share one link. You can also send files later, in reply to the practice.

The country of the phone number is suggested from your IP address, which is not stored for this (IP Geolocation by DB-IP).

Address
Özdemir Plaza, Bülent Ecevit Blvd. No:42
Fener Mah., 07160 Muratpaşa
Antalya, Türkiye
Opening hours
Monday–Saturday 09:00–18:00 · Sunday closed

References

  1. Damato BE. [The MOLES scoring system for melanocytic choroidal tumors: validation at Moorfields]. Eye, 2022. nature.com
  2. Jahnke et al. [German validation of the MOLES and TFSOM-DIM scores in 695 nevi and 53 melanomas]. Scientific Reports, 2024. nature.com
  3. Shields CL, et al. [Imaging features of 3,806 choroidal nevi and risk factors for transformation into melanoma in 2,355 cases]. Retina, 2019. Europe PMC
  4. American Academy of Ophthalmology. Distinguishing choroidal nevus from choroidal melanoma. EyeNet Magazine. aao.org
  5. National Cancer Institute. [Retinoblastoma treatment (PDQ®), health professional version: presenting signs, diagnosis and imaging]. cancer.gov
  6. EyeWiki (American Academy of Ophthalmology). Ocular Surface Squamous Neoplasia. eyewiki.org
  7. EyeWiki (American Academy of Ophthalmology). Conjunctival Melanocytic Tumors. eyewiki.org
  8. EyeWiki (American Academy of Ophthalmology). Pterygium. eyewiki.org
  9. EyeWiki (American Academy of Ophthalmology). Sebaceous Carcinoma. eyewiki.org
  10. EyeWiki (American Academy of Ophthalmology). Rhabdomyosarcoma. eyewiki.org
  11. EyeWiki (American Academy of Ophthalmology). Lacrimal gland tumors. eyewiki.org
  12. EyeWiki (American Academy of Ophthalmology). Evisceration. eyewiki.org
  13. Bartalena L, et al. The 2021 European Group on Graves' Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol, 2021. doi.org
  14. Burch HB, et al. Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association. Thyroid, 2022. doi.org

Need an ocular oncology opinion?

Send your scans and reports for a review by Prof. Türkoğlu, or book a consultation in Antalya. Adults and children are seen.

Send a request